$LH 4/A SEC Filings

Filed On	Filing
15 Feb 2022	Form 4/A: Williams R Sanders, Director Granted 742 Restricted Stock Unit
07 Feb 2020	Form 4/A: van der Vaart Sandra D, SVP, Global General Counsel Granted 900 Restricted Stock Unit · Granted 3,900 Non-qualified Stock Options
02 Nov 2010	Form 4/A: Walton Andrew Scott, EVP Sold 881 shares ($71.4K)
30 Jul 2010	Form 4/A: Conrad Andrew J, EVP, Chief Scientific Officer Bought 6,100 shares ($453K)
18 Feb 2009	Form 4/A: Walton Andrew Scott, EVP Gave up 408 shares to cover exercise price or tax ($25.5K)
18 Feb 2009	Form 4/A: King David P, Director Gave up 1,861 shares to cover exercise price or tax ($116K)
18 Feb 2009	Form 4/A: Hayes William B, Chief Financial Officer, EVP Gave up 718 shares to cover exercise price or tax ($44.8K)
18 Feb 2009	Form 4/A: Hardison Don M, EVP, COO Gave up 858 shares to cover exercise price or tax ($53.6K)
06 Mar 2008	Form 4/A: Smith Bradford T, Director Sold 150 shares ($11.6K)
05 Mar 2008	Form 4/A: Hayes William B, Chief Financial Officer, EVP Sold 1,918 shares ($152K)
06 Apr 2007	Form 4/A: Mac Mahon Thomas P, Director Sold 28,300 shares ($2.04M)
06 Apr 2007	Form 4/A: Mac Mahon Thomas P, Director Sold 86,963 shares ($6.28M)
09 Mar 2007	Form 4/A: Hayes William B, Chief Financial Officer, EVP Sold 2,251 shares ($181K)
23 Jan 2006	Form 4/A: Lai Goldman Myla, EVP & Chief Medical Officer Received 37,046 shares by exercise or conversion ($1.45M) · Sold 37,046 shares ($2.04M)
05 May 2003	Form 4/A: Elingburg Wesley R, EVP, CFO, and Treasurer
02 Apr 2003	Form 4/A
02 Apr 2003	Form 4/A

Comments